Aviana Molecular Technologies Overview

  • Founded

  • 2008

Founded
  • Status

  • Private

  • Employees

  • 9

Employees
  • Latest Deal Type

  • Crowdfunding

  • Latest Deal Amount

  • $37.3K

  • Investors

  • 3

Aviana Molecular Technologies General Information

Description

Developer of point of care diagnostic devices designed for diagnostic of infections for human and veterinary healthcare industries. The company's point of care diagnostic devices offers biosensors that detect specific infections within 15 to 20 minutes, enabling medical professionals and non-lab trained health care professionals to detect infections and start treatment.

Contact Information

Website
www.avianamolecular.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Commercial Products
Other Healthcare Technology Systems
Primary Office
  • 3251 Progress Drive
  • Orlando, FL 32826
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aviana Molecular Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Equity Crowdfunding 23-Jan-2020 $37.3K 00.000 Completed Generating Revenue
5. Angel (individual) 13-Mar-2017 00.000 Completed Generating Revenue
4. Grant 08-Jun-2016 00.000 Completed Generating Revenue
3. Accelerator/Incubator 00.000 Completed Generating Revenue
2. Angel (individual) $1.3M $1.48M Completed Generating Revenue
1. Accelerator/Incubator 24-Sep-2015 $175K $175K Completed Startup
To view Aviana Molecular Technologies’s complete valuation and funding history, request access »

Aviana Molecular Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of point of care diagnostic devices designed for diagnostic of infections for human and veterinary healthcare
Diagnostic Equipment
Orlando, FL
9 As of 2022
00.000
000000000000 00.000

00000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000000000 000000000
Alameda, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
0000000000 000000000
Sunnyvale, CA
0000 As of 0000
000.00
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aviana Molecular Technologies Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alveo Venture Capital-Backed Alameda, CA 00 000.00 00000000000 000.00
0000000 Formerly VC-backed Sunnyvale, CA 0000 000.00 0000000000
00000000 000000000 Corporation Cincinnati, OH 000 000000&0
You’re viewing 3 of 3 competitors. Get the full list »

Aviana Molecular Technologies Patents

  • 31

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Aviana Molecular Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3069148-A1 Signal amplification in biosensor device Pending 11-Jul-2017 000000000000
EP-3652341-A1 Signal amplification in biosensor device Pending 11-Jul-2017 000000000000
EP-3652341-A4 Signal amplification in biosensor device Pending 11-Jul-2017 000000000000
US-20200132583-A1 Signal amplification in biosensor device Pending 11-Jul-2017 000000000000
AU-2018301295-A1 Signal amplification in biosensor device Pending 11-Jul-2017 G01N33/54373
To view Aviana Molecular Technologies’s complete patent history, request access »

Aviana Molecular Technologies Executive Team (4)

Name Title Board Seat Contact Info
Vanaja Ragavan MD Founder, President, Chief Executive Officer & Board Member
Todd Mirzai MD Advisor
Paul Sansone Chief Financial Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Aviana Molecular Technologies Board Members (6)

Name Representing Role Since
Edward Peterson Aviana Molecular Technologies Board Member & Global General Manager 000 0000
Gary Foster MD Self Board Member 000 0000
Steven Waite Aviana Molecular Technologies Board Member 000 0000
Vanaja Ragavan MD Aviana Molecular Technologies Founder, President, Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Aviana Molecular Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aviana Molecular Technologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NASA Bioventures Venture Capital Minority 000 0000 000000 0
Institute for Commercialization of Florida Technology Not-For-Profit Venture Capital Minority 000 0000 000000 0
University of Central Florida Business Incubator Accelerator/Incubator 000 0000 000000 0
To view Aviana Molecular Technologies’s complete investors history, request access »

Ready to get started?

Request a free trial